相关实验视频
Updated: Jul 5, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
缓解升级的治疗指示对于那些达到代谢目标的患者
Ana Cristina García-Ulloa1, Salvador Jaime-Casas2, Johanna Rosado-Lozoya2
1Centro de Atención Integral del Paciente con Diabetes (CAIPaDi), Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Diabetes research and clinical practice
|January 20, 2024
概括
对某些患者来说,降低常见药物如低血糖药,他类药和抗高血压药的处方可能是可能的. 仔细监测是必不可少的,因为需要更多的证据来充分支持这些抑郁症决定.
科学领域:
- 药理学 药理学是指药理学的学科.
- 老年病的医生 老年病的医生
- 内部医学 内部医学
背景情况:
- 对于减缓糖尿病治疗的指导意见有限,尽管有证据表明可以启动/加强治疗.
- 治疗减强可以减少多药,过度治疗和不良药物事件.
- 停止处方常用药物对于改善患者的治疗结果和降低医疗保健成本至关重要.
研究的目的:
- 综合目前关于抑郁症常见药物类别的建议.
- 在医疗保健专业人员之间就抑郁症的策略建立共识.
- 为了确定适合减缓处方的患者群体和药物类型.
主要方法:
- 对2010年至2022年间发表的文章进行了四个数据库的系统审查.
- 文献根据药物类别进行分类:尿酸,低血糖,降脂和精神药物.
- 对于每个药物类别,分析了抑郁的方法和相关证据.
主要成果:
- 低血糖药物:降低药物的处方策略集中在较新的药物和老年患者的胰岛素上;胰岛素降低与A1c降低相关.
- 降脂剂:研究表明,对胆固醇非常低和心血管事件减少的患者有好处.
- 抗高血压药物:在年轻的血压控制和少数并发症的患者中,中止是可行的;对于尿酸治疗没有发现降级建议.
结论:
- 处方降低血糖,他类药物,抗高血压药物和尿酸降低剂在特定的患者群体中可能是可行的.
- 在停止处方后,定期监测患者至关重要,以确保持续的疗效和安全.
- 需要进一步的研究,以提供全面的证据支持广泛的抑郁症实践.
相关概念视频
Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
Acute Pancreatitis II: Clinical Manifestations and Management
125
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
125
Oral Hypoglycemic Agents: Biguanides and Glitazones
204
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
204
Psychosis: Goals of Pharmacotherapy
133
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
133
Increased pulse rate
667
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
667
Hypoglycemia and Glucagon
263
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
263

